Solanbridge Group, Inc. Announces it has Withdrawn its 504 Public
Offering
CHARLOTTE, N.C., Feb. 5, 2013 /PRNewswire/ -- Solanbridge
Group, Inc. (OTC.PK: SLNX) is pleased to announce that it has had
any shares issued pursuant to the exemption found in Rule 504
returned to the Company's treasury. The current management of
Solanbridge Group, Inc. also discovered that the prior management
of the Company made a calculation error related to the Company's
freely tradable share structure, which is currently 17,234,746 and
has remained unchanged since new management has taken control.
Solanbridge Group, Inc. also announces it has accepted the
resignation of Matthew Nicoletti from all of his
positions with the company on January 31,
2013.
About Solanbridge Group, Inc:
Solanbridge Group, Inc. is an investment company and diversified
holding company whose main business is purchasing revenue
generating foreign and domestic private/public companies.
Solanbridge Group is currently comprised of two subsidiaries,
Advanced Medical Sales LLC and Adventure Option, Inc.
Advanced Medical Sales supplies Transcutaneous Electrical nerve
stimulators, Therapeutic Deep Tissue Ultrasound units,
Micro-current sub sensory units and Electric Muscle stimulation
units along with numerous joint and extremity therapeutic sleeves
directly to Physicians offices, Chiropractic offices and Physical
Therapy Centers. The devices are used for the treatment of acute
and chronic pain as well as post-operatively for muscle
rehabilitation either with or without prescribed Narcotic
Analgesics, NSAIDS, Muscle Relaxants and/or steroids depending on
each patient's specific needs and/or wishes. The Medical Provider
prescribes and fits the patient with one or more of these devices
with respect to the Medical Necessity of the patient. Electrodes
are sent to maintain the proper use of the equipment monthly to
each patient by Advanced Medical and reimbursement to Advanced
Medical is made by the patient's insurance company. With the very
recent regulations by Governmental and State Medical Boards to
limit the prescribing of Pain Medication by Physicians and the
policing of Physician's prescribing habits by Electronic Narcotic
Prescription Databases, there has been a growing concern on the
part of Physicians and increasing pressure on Medical Boards by
patient advocacy groups to make significant changes.The above
facts, coupled with the recent realization of the harmful
Cardiovascular effects of all NSAIDS, the changes of commonly used
muscle relaxants from general RX's to Controlled substances (i.e.
SOMA) and the many adverse effects from the use of Steroids have
presented Advanced Medical with the opportunity to be a leader in
the areas of Pain Management and Post Operative Rehabilitation.
Solanbridge's wholly owned subsidiary, Adventure Option, Inc.,
has an extensive background in the sex life enhancement industry.
The company has formulated some of the most exciting products in
the industry today, which include Morning Glory (male arousal
capsule) and Evening Delight (Female arousal gel) formulas .
Adventure Option's library of formulas consists of over 40 products
that can be customized to meet your company's needs. The Company
plans on taking its new products to market within the next twelve
months and is set to move its headquarters to Charlotte, North Carolina.
Contact:
investor@solanbridge-group.org
SOURCE Solanbridge Group, Inc.
